First batch of AstraZeneca Covid-19 vaccine expected in first half of 2021


PETALING JAYA: The first deliveries of the AstraZeneca-Oxford University Covid-19 vaccine to Malaysia are expected in the first half of 2021, says the pharmaceutical company.

AstraZeneca Malaysia country president Dr Sanjeev Panchal said the company will be providing 6.4 million doses of its potential vaccine, AZD1222, at no profit during the period of the pandemic.

"I am grateful for the government’s guidance and leadership, and look forward to deepening our cooperation to fight Covid-19.

"When the government, private sector and academia join hands, so much can be achieved to protect people's lives and build a healthier Malaysia," he said in a statement Wednesday (Dec 23).

AZD1222 is co-invented by Oxford University and its spinoff company Vaccitech.

AstraZeneca said under the agreement, it will expand its global manufacturing capacity to ensure a dedicated supply of the vaccine for Malaysia.

"This takes place in parallel with the ongoing clinical trials in the United Kingdom, United States, Brazil, South Africa, Japan and Russia.

"Results of an interim analysis of the Phase III programme conducted by Oxford University with AZD1222, peer-reviewed and published in The Lancet on Dec 8, demonstrated that the vaccine is safe and effective at preventing symptomatic Covid-19 and that it protects against severe disease and hospitalisation," said the company.

AstraZeneca said it was working together on the preparations for swift and science-led regulatory approval with the Health Ministry and the Science, Technology and Innovation Ministry to ensure that the potential vaccine lives up to the highest safety standards and that its introduction complies with the healthcare regulations of Malaysia.

On Tuesday (Dec 22), Prime Minister Tan Sri Muhyiddin Yassin announced that the government had signed an agreement with AstraZeneca for the procurement of an additional 10% or 6.4 million doses of their Covid-19 vaccine.

He said that the government is also in final negotiations with Sinovac, CanSino and Gamaleya to secure a vaccine supply increase to cover more than 80% or 26.5 million of the country's total population.

The government had previously signed preliminary agreements with Covax and Pfizer for the procurement of the Covid-19 vaccine to secure a vaccine supply of 30% of the population.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

83% readers found this article insightful

Next In Nation

Body found alongside Sg Endau, Mersing
No congestion on public transport as passenger numbers were low, says Dr Wee
Poor drainage among causes of recurring flash floods in Sabah, says Bung Moktar
Dr Wee says work continues from home during MCO
Frontliners can't do it alone in fight against Covid-19, says PJ OCPD
Public transport services to continue through MCO, says Dr Wee
Last of Johor flood victims allowed to return home as water recedes
Emergency has not turned M'sia into dictatorship, says PM's principal private secretary
Police in Labuan hand out RM1,000 compounds to 41 people for MCO violations
Covid-19: Apollo Market in Penang ordered to close from Monday (Jan 18)

Stories You'll Enjoy